COVID-19

The “Indian” variant is partially resistant to the vaccine.

This is dark news on the vaccination front. According to a study published on June 3 in the journal Lancetthe messenger RNA vaccine developed by Pfizer / BioNTech against Covid-19 will be significantly reduced compared to the Delta or B.1.617.2 variant first identified in India and is believed to have 60% higher infectivity than the English variant itself by itself is already more transferable than the transmission line that preceded it.

Read also: Is the Indian version an English version of the summer?

Back to top button